Loading briefing details...
Loading briefing details...
News Brief
By: PointLine Media Research & Editorial Team
Category:Business,Health,Industry
June 22, 2026
This program matters because it transforms routine mammograms into a powerful tool for early heart disease risk detection in women, a leading cause of death. By integrating AI and facilitating coordinated cardiovascular care, it empowers women and providers to intervene sooner, potentially saving lives and improving long-term health outcomes across Central Alabama.
Birmingham OB/Gyn, in partnership with Onsite Women's Health, has launched "Mammo with Heart," an innovative screening program. This initiative utilizes artificial intelligence (AI) to identify breast arterial calcifications (BAC) during routine mammography. The program offers women and their healthcare providers crucial insights into cardiovascular risk without additional imaging, addressing the critical fact that heart disease remains the leading cause of death among women across Central Alabama.
Employing FDA-cleared CureMetrix® cmAngio® technology, Mammo with Heart analyzes standard mammogram images for BAC, which research suggests is associated with increased cardiovascular risk. This allows a single, routine mammogram to provide valuable information for both breast and heart health. Dr. Ashley Przybysz emphasizes the program's ability to facilitate earlier conversations about cardiovascular health before serious disease develops.
To ensure comprehensive patient support, Birmingham OB/Gyn is establishing a coordinated cardiovascular care pathway with Alabama Cardiovascular Group (ACG). This aims to connect women identified with elevated risk to timely specialty evaluations. Mammo with Heart is now available, reinforcing Birmingham OB/Gyn’s commitment to advancing women's health through innovation and integrated care. For details, visit birminghamobgyn.com or call 205-933-8334.